Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial.
Respir Res. 2022 Apr 7;23(1):85. doi: 10.1186/s12931-022-01974-2.
Respir Res. 2022.
PMID: 35392908
Free PMC article.
Clinical Trial.
Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.
Costabel U, Inoue Y, Richeldi L, Collard HR, Tschoepe I, Stowasser S, Azuma A.
Costabel U, et al. Among authors: tschoepe i.
Am J Respir Crit Care Med. 2016 Jan 15;193(2):178-85. doi: 10.1164/rccm.201503-0562OC.
Am J Respir Crit Care Med. 2016.
PMID: 26393389
Clinical Trial.
Item in Clipboard
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.
Collard HR, Richeldi L, Kim DS, Taniguchi H, Tschoepe I, Luisetti M, Roman J, Tino G, Schlenker-Herceg R, Hallmann C, du Bois RM.
Collard HR, et al. Among authors: tschoepe i.
Eur Respir J. 2017 May 19;49(5):1601339. doi: 10.1183/13993003.01339-2016. Print 2017 May.
Eur Respir J. 2017.
PMID: 28526798
Free article.
Clinical Trial.
Item in Clipboard
Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2.
Bahleda R, Varga A, Bergé Y, Soria JC, Schnell D, Tschoepe I, Uttenreuther-Fischer M, Delord JP.
Bahleda R, et al. Among authors: tschoepe i.
Br J Cancer. 2018 Feb 6;118(3):344-352. doi: 10.1038/bjc.2017.436. Epub 2018 Jan 16.
Br J Cancer. 2018.
PMID: 29337963
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials.
Hoffmann-Vold AM, Volkmann ER, Allanore Y, Assassi S, de Vries-Bouwstra JK, Smith V, Tschoepe I, Loaiza L, Kanakapura M, Distler O.
Hoffmann-Vold AM, et al. Among authors: tschoepe i.
Lancet Rheumatol. 2022 Oct;4(10):e679-e687. doi: 10.1016/S2665-9913(22)00215-6.
Lancet Rheumatol. 2022.
PMID: 38265966
Item in Clipboard
Cite
Cite